Skip to content

Proveris

About us

Our Mission

To help our customers bring optimally-performing orally inhaled and nasal drug products to patients around the world.

Testing The Truth

Our name says it all:
Proveris: from Latin probare (test, approve, demonstrate), and veritas (truth)

Proveris Scientific Corporation delivers innovative testing platforms, laboratory services, and deep product knowledge to customers who develop, manufacture or test orally inhaled and nasal drug products (OINDPs).

The company is privately owned, and was founded in 1995. Our worldwide customer base includes the top innovator and generic pharmaceutical companies, device manufacturers, CDO/CRO/CMOs, and regulatory agencies.

By understanding the critical quality attributes affecting the performance of OINDPs, and effectively controlling them from a testing and patient usability perspective, our expert team of engineers, scientists, and service professionals can help you:

  • Ensure successful product development, and prevent late-stage development failures
  • Realize significant savings in time and resources by streamlining testing workflows and eliminating manual processes
  • Evaluate the suitability of various OINDP delivery devices for compound and optimize device parameters for maximum efficacy
  • Eliminate testing variables to maintain batch-to-batch reproducibility, simplifying regulatory submissions

Corporate Values

When you’re successful, we’re successful

We strive to deliver measurable value in everything we do, by:

  • Only entering markets where we can make a significant contribution to our customers’ success
  • Providing complete solutions that include technical services, systems, consumables and educational training
  • Always maintaining the strictest quality standards, even when our business is growing rapidly
  • Constantly driving new technology development for better spray characterization, capture and analysis
  • Continuing to deepen our understanding of the science of sprays and aerosols and how it relates to drug delivery and patient care
  • Hiring, retaining and working with people who are committed to the highest standards of performance
  • Fostering and creating a work environment that encourages active participation, challenging problem solving and teamwork

Milestones in Proveris Scientific's History

Scroll along to follow our journey →

Founded
Proveris Scientific is founded in Waltham, MA as Image Therm Engineering, Inc.
1999
First Order
The first order for a SprayVIEW® system is received.
2001
Patent Application
A patent application is filed for innovative automated actuation technology leading to the launch of Proveris Scientific’s now gold standard Vereo® product family.
2002
New FDA Draft Guidance
With technical inputs from Proveris Scientific’s founder, Dino Farina, the US FDA issues a new Draft Guidance to Industry for nasal sprays and aerosols with new methods for in vitro characterization, which includes non-impaction spray pattern and plume geometry measurements based on laser light sheet, high-speed digital imaging, and the use of automated actuation to mimic human usage.
2003-2006
Lab Services Launched
Proveris Scientific launches its laboratory service offerings focused on early-stage method development for spray and aerosol product characterization using its Ergo®, Vereo, and SprayVIEW technologies.
2005
Viota® Released
Proveris Scientific releases its flagship software platform, Viota, to support its growing customer base around the world with a focus on meeting their demanding requirements for ease of use and regulatory compliance.
2006
Patent Issued
The U.S. Patent and Trademark Office issues Proveris Scientific a patent on technology related to measuring manual actuation of spray devices.
2010
First NIFDC Install
Proveris Scientific installs the first instrument purchased by the China National Institute of Food and Drug Control (NIFDC) at its Beijing facility.
2014
Patent Filed
Proveris Scientific files patent applications related to innovative technologies for spray pattern measurement, as well as dose content uniformity measurement of inhaler products.
2018
INVIDA® Launched
Proveris Scientific launches the INVIDA™ In Vitro Inhalation Drug Analysis platform to study aerosol performance under human-realistic breathing conditions and employing physiologically relevant models of the human respiratory tract. The platform allows for quantification of regional deposition and real time flow visualization of inhaled drug products.
2019
New Test Services Added
Proveris Scientific adds plume front velocity and evaporation rate testing to its in vitro laboratory test service offering of bio equivalence studies for metered dose inhalers and soft mist inhalers.
2022
Viota 9.1 Software Released
Proveris Scientific releases a major software update enabling the ability to make automated Plume Front Velocity (PFV) and Spray Duration Measurements on a SprayVIEW® System and Unit Dose Sample Collection on the Indizo® Nasal Spray Collection System.
2024
Vereo® SWC System Released
Proveris Scientific releases the Vereo® Spray, Weigh, Collect (SWC) System, a benchtop nasal spray testing solution that utilizes trusted Viota® software and offers automated actuation, sample collection, and weighing for Dose Content Uniformity testing.
2024
1995
First Patent
Image Therm’s first patent application is filed for its innovative spray pattern and plume geometry technology leading to the launch of the now gold standard SprayVIEW® product family.
2000
First SprayVIEW® Systems Installed
The first three SprayVIEW systems are placed in three different countries at leading pharmaceutical companies.
2001
FDA Tests SprayVIEW®
The first SprayVIEW instrument is installed at the U.S. Food and Drug Administration (FDA) at its St. Louis, Missouri, facility for independent evaluation of the technology and its application to spray and aerosol drug product testing.
2003
Patents Issued
The U.S. Patent and Trademark Office issues patents on Proveris Scientific’s spray pattern/plume geometry technology and software, as well as its automated actuation technology.
2004
Indizo® Released
Proveris Scientific releases the Indizo Automated Nasal Spray Collection System for fully walkaway pump delivery and spray content uniformity testing.
2006
New Name, Proveris
Image Therm Engineering, Inc., adopts a new name (Proveris Scientific Corporation) to demonstrate its focus and dedication to a science-based approach of “testing the truth.”
2010
Patent Issued
The U.S. Patent and Trademark Office issues Proveris Scientific a patent related to measuring spray angle.
2014
Patent Filed
Proveris Scientific files a patent application related to better techniques for collecting emitted doses from inhaler products and analysis of drug content.
2016
Kinaero® Released
Proveris Scientific releases its Kinaero High-Throughput pMDI Fire Down System for automated shake and fire of up to 10 pMDI devices simultaneously, supporting through-life testing workflows.
2019
SIFDC First Install
Proveris Scientific installs the first instrument purchased by the Shanghai institute for Food and Drug Control (SIFDC) in Shanghai, China, and begins offering testing services for customers in Asian markets.
2019
Kinaero CxTM Released
Proveris Scientific releases its Kinaero Cx pMDI Collection System for automated shaking, actuation, and sample collection for delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD).
2023
Nasal Cast Service Released
Proveris Laboratories releases the Proveris Nasal Cast, a highly realistic model of the human nasal cavity. Paired with the Proveris human-realistic Breathing Simulator, the in vitro tool enables testing services that accurately quantify drug deposition within the 5 distinct regions of the nasal cavity.
2024
Proveris DUSA Released
Proveris Scientific releases its Dosage Unit Sampling Apparatus (DUSA), a specialized tool designed to analyze the delivered dose and total drug release from inhalation products like pressurized Metered Dose Inhalers (pMDIs).

Our Leadership Team

Daniel Tereau

President & CEO

Dino J. Farina, MS, EME

Founder and Chief Technology Officer

Chip Leveille

Executive Advisor to the CEO and Board

Ben Okorodudu

Vice President of Sales

JOANNE MATHER

Senior Director
Marketing

Timothy Fallon

Associate Director
Product Development

Maria Smith

Director of Application and Business Development

Eric Uffman

Director of Sales, Americas

John Grega

DIRECTOR OF QUALITY ASSURANCE

STEPHEN HOULIHAN

Director of Finance

CHRIS LE BLANC

Senior Manager
Operations

Commitment to Quality

We are certified to the ISO 9001:2015 standard by TUV Rheinland of North America.

Like many of our pharmaceutical industry customers, we have adopted a system-wide Quality-by-Design (QbD) approach. QbD ensures quality by developing a thorough understanding of the sensitivity of a finished product to all the components and processes involved in manufacturing that product.

We are dedicated to meeting and exceeding customer expectations in everything we do. Through our Quality Policy, Proveris Scientific strives to:

  • Deliver the highest quality products and services to its global customers
  • Deliver its products and services on time and at competitive rates
  • Become the standard bearer for products and services in the industries it serves
  • Commit to the continuous improvement of our quality management system
View Quality Certificate

Proveris News

Keep up-to-date with all things Proveris conferences, events, & other industry news. 

Products

Optimize your workflow with our complete suite of testing solutions and technologies.

Lab Services

Make informed decisions with study results & consultations with our application scientists.